Tumour budding in invasive breast carcinoma and its correlation with histopathological prognostic parameters and hormone receptor status

被引:2
|
作者
Kundu, Tamanna [1 ]
Giri, Ranjana [1 ]
Hota, Subhransu K. [1 ]
Sahu, Subrat K. [2 ]
Senapati, Urmila [1 ]
机构
[1] KIIT Univ, Dept Pathol, Kalinga Inst Med Sci, Bhubaneswar, Odisha, India
[2] KIIT Univ, Dept Oncosurg, Kalinga Inst Med Sci, Bhubaneswar, Odisha, India
关键词
Breast carcinoma; pan cytokeratin; tumor budding;
D O I
10.4103/jcrt.jcrt_656_22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Tumor Budding (TB) is emerging as an important sensitive indicator of aggressiveness over traditional histopathological variables such as lymph node metastasis and lymphovascular invasion because TB at the invasive front was postulated as the first step of invasion and metastasis. But the role of TB in breast carcinoma is not yet standardized. Aim: This study aims to assess the prognostic significance of TB in breast carcinoma. Objectives: To study and grade TB in invasive breast carcinoma and correlate it with known histopathological prognostic markers and hormone receptor status. Materials and Methods: In this ambispective study, 51 cases of invasive breast carcinoma undergoing radical surgery were studied from September 2017 to September 2021. Tumor buds were defined as a single or cluster of up to four tumor cells at the invasive front of the tumor and were counted by using IHC Pancytokeratin in 200X and graded into a three-tier grading system. The correlation between TB with established histopathological parameters and hormone receptor status was studied. A Chi-square test was used and a P value < 0.05 was considered significant. Results: TB was seen in all cases of invasive breast carcinoma. Grade 1 TB was seen in 37.26% (19/51) of cases and Grade 2 TB and Grade 3 TB in 31.37% (16/51) of cases each. There was a lack of significant correlation between TB with histologic grade, lymph node status, and HER2 neu. Correlation between TB with Estrogen receptor (ER), Progesterone receptor (PR), and American Joint Committee on Cancer (AJCC) Prognostic stage group was noted but it was not statistically significant. Conclusion: Although several studies have confirmed the prognostic value of TB in breast carcinoma, they had used several different methods of assessment. So, there is a need for a standardized method for the assessment of TB in breast carcinoma. Further standardization of TB may add its value as a prognostic factor.
引用
收藏
页码:S664 / S668
页数:5
相关论文
共 50 条
  • [31] Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters
    Hemalatha, A.
    Suresh, T. N.
    Kumar, Harendra M. L.
    INDIAN JOURNAL OF CANCER, 2013, 50 (03) : 189 - 194
  • [32] Analyzing Androgen Receptor Expression in Breast Cancer: Insights into Histopathological Parameters and Hormone Receptor Status Among Indian Women
    Thakkar, Nidhiben Harshadkumar
    Osama, Md Ali
    Dhawan, Shashi
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (04) : 789 - 795
  • [33] HORMONE RECEPTORS LEVELS IN 700 INVASIVE BREAST-CARCINOMA - CORRELATION WITH VARIOUS PATHOLOGICAL PARAMETERS
    KRIAKA, A
    GABRIELIDES, CG
    PATHOLOGY RESEARCH AND PRACTICE, 1985, 180 (03) : 288 - 288
  • [34] Hormone Receptor Status in Breast Cancer and its Relation to Age and Other Prognostic Factors
    Pourzand, Ali
    Fakhree, M. Bassir A.
    Hashemzadeh, Shahryar
    Halimi, Monireh
    Daryani, Amir
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2011, 5 : 87 - 92
  • [35] Mammary carcinoma in a mare: clinical, histopathological and steroid hormone receptor status
    Laus, Fulvio
    Mariotti, Francesca
    Magi, Gian Enrico
    Spaziante, Daniele
    Fugazzola, Maria Carlotta
    Tesei, Beniamino
    PFERDEHEILKUNDE, 2009, 25 (01): : 18 - 21
  • [36] Studying the Correlation between Androgen Receptor (AR) Expression and Prognostic Factors in Invasive Breast Carcinoma
    Safi, Sara
    Ehteram, Hasan
    Moraveji, Alireza
    Khamechian, Tahere
    Nadermohammadi, Soheila
    WORLD FAMILY MEDICINE, 2018, 16 (01): : 181 - 187
  • [37] The prognostic value of the tumour-stroma ratio in invasive breast carcinoma
    Mesker, W. E.
    Vangangelt, K.
    Tollenaar, L.
    van Pelt, G.
    Dekker, T.
    Kuppen, P.
    Tollenaar, R.
    VIRCHOWS ARCHIV, 2018, 473 : S52 - S52
  • [38] The prognostic value of the tumour-stroma ratio in invasive breast carcinoma
    Mesker, W. E.
    Vangangelt, K.
    Tollenaar, R.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S48 - S48
  • [39] The histopathological and molecular features of breast carcinoma with tumour budding-a systematic review and meta-analysis
    Lloyd, Angus J.
    Ryan, Eanna J.
    Boland, Michael R.
    Abd Elwahab, Sami
    Malone, Carmel
    Sweeney, Karl J.
    Barry, Kevin M.
    McLaughlin, Raymond
    Kerin, Michael J.
    Lowery, Aoife J.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (03) : 503 - 514
  • [40] Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma
    Braun, Marcin
    Piasecka, Dominika
    Tomasik, Bartlomiej
    Mieczkowski, Kamil
    Stawiski, Konrad
    Zielinska, Aleksandra
    Kopczynski, Janusz
    Nejc, Dariusz
    Kordek, Radzislaw
    Sadej, Rafal
    Romanska, Hanna M.
    CANCERS, 2020, 12 (09) : 1 - 18